Page 98 - Read Online
P. 98

Ottewell et al. J Cancer Metastasis Treat 2021;7:11  https://dx.doi.org/10.20517/2394-4722.2021.14  Page 17 of 20

               human bone implants; these models allow the investigation of the growth of heterogeneous patient samples
               from different tumour subtypes and their ability to metastasise and interact with a human bone
               environment in a mouse with a semi-competent human immune system [23,52,54] . These models, however, are
               far from perfect and are expensive and difficult to run. It is unclear how active the human B cells are in this
               model and whether any other human immune cell subsets are present; further work is required to establish
               this. A mouse model of human breast cancer to human bone metastasis with a fully competent immune
               system would be a highly relevant tool. Extensive work has been carried out by various research groups to
               make mouse models with a human-specific immune system for research purposes. In these models, NSG
               mice are irradiated prior to injection of human haematopoietic stem cells; the resulting mice have been
               successfully used to show effects of immunotherapies in various cancer types including breast cancer [69-71] . It
               would be interesting to see if the same process could be used to produce a mouse model of human breast
               cancer metastasis to human bone with a competent human immune system and whether this would be
               possible given the difficulties of obtaining all three samples (bone, primary tumour and haematopoietic
               stem cells) from the same donor to avoid auto immunity.

               In conclusion, there is a large array of mouse model systems available to researchers for investigating
               various parameters associated with breast cancer bone metastasis. When used in combination, these model
               systems cover most aspects associated with the metastatic process including growth at the primary site,
               spontaneous spread to bone, homing to the metastatic niche, dormancy and metastatic outgrowth. Models
               are also available to investigate the effects of immune cells on these processes. However, to date, there is not
               one model system that covers all of the processes, and there are no systems which reliably model
               spontaneous development of the primary tumour followed by bone metastasis. Researchers must therefore
               select the most appropriate model system(s) for their research question and interpret their data accordingly,
               giving special consideration to the need for experiments to be performed either with multiple cell lines or in
               multiple systems before reliable conclusions can be made.

               DECLARATIONS
               Authors’ contributions
               Wrote the manuscript and provided data for Figures 1-3: Ottewell PD
               Edited the manuscript and provided text and data for Figure 4: Lawson MA


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.
   93   94   95   96   97   98   99   100   101   102   103